Dinesh S. Rao

University of California, Los Angeles — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

42h-index12.5kcitations150works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(39), Cancer-related molecular mechanisms research(33), Acute Myeloid Leukemia Research(27), RNA modifications and cancer(24), Circular RNAs in diseases(15)

Publications149 total

A small molecule inhibitor of RNA-binding protein IGF2BP3 shows anti-leukemic activity
Haematologica·2025Open Access
MicroRNA regulation of messenger RNA vaccine responses in a mouse model of acute myeloid leukemia 3050
The Journal of Immunology·2025Open Access
IGF2BP3 remodels the microRNA targeting landscape in MLL-AF4 leukemia
2025Open Access
IGF2BP3 redirects glycolytic flux to promote one-carbon metabolism and RNA methylation
Cell Reports·2025· 2 citedOpen Access
Distinct roles for NF-κB in hematopoietic stem cells and the bone marrow milieu in promoting hematopoietic aging
Cell Reports·2025· 2 citedOpen Access
A small molecule inhibitor of RNA-binding protein IGF2BP3 shows anti-leukemic activity
2025· 2 citedOpen Access
A microRNA-regulated transcriptional state defines intratumoral CD8+ T cells that respond to immunotherapy
Cell Reports·2025· 7 citedOpen Access
Distinct causes of three phenotypic hallmarks of hematopoietic aging
2025· 1 citedOpen Access
Population dynamics modeling reveals that myeloid bias involves both HSC differentiation and progenitor proliferation biases
Blood·2025· 13 citedOpen Access
An Overview on Immediate Drug Release of Pravastatin Drug
International Journal of Pharmaceutical Research and Applications·2025Open Access
Novel Small Molecule Inhibitor Against IGF2BP3 with Potent Anti-Leukemic Activity
Blood·2024Open Access
Regulation of Metabolism and Epitranscriptomic Modifications By RNA Binding Protein IGF2BP3
Blood·2024Open Access
Metabolic regulation of RNA methylation by the m6A-reader IGF2BP3
2024· 1 citedOpen Access
Envelope protein-specific B cell receptors direct lentiviral vector tropism in vivo
Molecular Therapy·2024· 6 citedOpen Access
Small molecule inhibition of RNA binding proteins in haematologic cancer
RNA Biology·2024· 10 citedOpen Access
Targeting IGF2BP3 enhances antileukemic effects of menin-MLL inhibition in MLL-AF4 leukemia
Blood Advances·2023· 13 citedOpen Access
Targeting IGF2BP3 Enhances Anti-Leukemic Effects of Menin-MLL Inhibition in MLL-AF4 Leukemia
Blood·2023· 1 citedOpen Access
Modeling Cell Population Dynamics in Early Hematopoiesis Reveals Mechanisms of Myeloid Bias Mediated By NFκB-Dysregulation
Blood·2023
NFκB Dysregulation in the Bone Marrow Niche Drives Epigenomic Reprogramming of Hematopoietic Stem Cells and Myeloid Bias
Blood·2023Open Access
IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma
Cancers·2023· 4 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

David Baltimore(18), Ryan M. O’Connell(17), Aadel A. Chaudhuri(8), Thilini R. Fernando(7), Mark Boldin(6), Jayanth Kumar Palanichamy(6), Priti D. Kumar(6), Theodora S. Ross(6), Konstantin D. Taganov(5), Lili Yang(5), Alejandro B. Balazs(5), Tiffany Tran(5), Jorge R. Contreras(5), Norma I. Rodríguez-Malavé(5), June L. Round(4), Jimmy L. Zhao(4), Giuseppe Basso(4), Martina Pigazzi(4), Teresa S. Hyun(4), Ikuko F. Mizukami(4)